Sunitinib in metastatic thymic carcinomas: Laboratory findings and initial clinical experience

Phase II study of sunitinib in men with advanced prostate cancer

(2009) M. Dror Michaelson et al.   ANNALS OF ONCOLOGY

Adjuvant Radiotherapy for Thymic Epithelial Tumors: A Systematic Review and Meta-Analysis

(2009) Robert J. Korst et al.   ANNALS OF THORACIC SURGERY

Long Lasting Response to the Multikinase Inhibitor Bay 43-9006 (Sorafenib) in a Heavily Pretreated Metastatic Thymic Carcinoma

(2009) Giancarlo Bisagni et al.   Journal of Thoracic Oncology

Emergency surgery in the era of molecular treatment of solid tumours

(2009) Piotr Rutkowski et al.   LANCET ONCOLOGY

Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR

(2009) K. Al-Nedawi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Multicenter, Phase II Trial of Sunitinib in Previously Treated, Advanced Non–Small-Cell Lung Cancer

(2008) Mark A. Socinski et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Study of Sunitinib Malate, an Oral Multitargeted Tyrosine Kinase Inhibitor, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

(2008) Harold J. Burstein et al.   JOURNAL OF CLINICAL ONCOLOGY

Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors

(2008) Matthew H. Kulke et al.   JOURNAL OF CLINICAL ONCOLOGY

Absence of gene mutations in KIT-positive thymic epithelial tumors

(2008) Masanori Tsuchida et al.   LUNG CANCER

Mutational status of EGFR and KIT in thymoma and thymic carcinoma

(2008) Kiyotaka Yoh et al.   LUNG CANCER

Response to sorafenib in cisplatin-resistant thymic carcinoma: a case report

(2008) Xiao-feng Li et al.   MEDICAL ONCOLOGY